Implantable NMR Microcoils in Rats: A New Tool for Exploring Tumor Metabolism at Sub-Microliter Scale?

Deborne, Justine; Pinaud, Noël; Crémillieux, Yannick

doi:10.3390/metabo11030176

Cited by 4 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The NMR detection volume reported here for the implanted device was found to be similar to those measured previously 14 , 15 , of the order of 1 μL, when evaluated by FEM modeling or measured by MRI. Comparison of the detection sensitivity obtained with the microcoil of the implanted device and a commercial surface coil designed for rat brain confirmed the importance of miniaturization to achieve sufficient sensitivity in the vicinity of the capillary used for CED.…”

Section: Discussionsupporting

confidence: 84%

“…We have previously reported results obtained with brain-implanted microcoils of comparable size in healthy and tumor-bearing rats 14 , 15 . In these studies, the concentrations, relative to tCr, of tCho, glutamine, glutamate, lactate, mI, tNAA and taurine obtained in the brain of healthy animals with the implanted microcoil were similar to those reported in the literature using standard extracorporeal NMR coils.…”

Section: Discussionmentioning

confidence: 99%

“…One solution to this sensitivity limitation is to design a dedicated NMR coil whose dimensions correspond to the volume to be examined, and to position it as close as possible to the region of interest. Reducing the size of the RF coil advantageously translates into an increase in coil sensitivity per unit volume, while positioning it in close proximity to the region of interest optimizes detection sensitivity in this region 11 – 15 .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

Deborne,

Benkhaled,

Bouchaud

et al. 2024

Sci Rep

Self Cite

View full text Add to dashboard Cite

The evaluation of the efficacy of a drug is a fundamental step in the development of new treatments or in personalized therapeutic strategies and patient management. Ideally, this evaluation should be rapid, possibly in real time, easy to perform and reliable. In addition, it should be associated with as few adverse effects as possible for the patient. In this study, we present a device designed to meet these goals for assessing therapeutic response. This theranostic device is based on the use of magnetic resonance imaging and spectroscopy for the diagnostic aspect and on the application of the convection-enhanced delivery technique for the therapeutic aspect. The miniaturized device is implantable and can be used in vivo in a target tissue. In this study, the device was applied to rodent glioma models with local administration of choline kinase inhibitor and acquisition of magnetic resonance images and spectra at 7 Tesla. The variations in the concentration of key metabolites measured by the device during the administration of the molecules demonstrate the relevance of the approach and the potential of the device.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

Deborne,

Benkhaled,

Bouchaud

et al. 2024

Sci Rep

Self Cite

View full text Add to dashboard Cite

show abstract

“…A microcoil configuration close to the implanted microcoil of the device was previously investigated 12,13 . The results reported on healthy animals and tumor-bearing animals demonstrated the feasibility of the approach and the key role played by the miniaturization of the coil for enhancing the detection sensitivity on very small volume.…”

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact: application to brain tumors

Deborne,

Benkhaled,

Bouchaud

et al. 2023

Preprint

View full text Add to dashboard Cite

The evaluation of the efficacy of a drug is a fundamental step in the development of new treatments or in the personalized therapeutic strategies and management of patients. Ideally, this evaluation should be rapid, possibly in real time, simple to implement and reliable. Moreover, for patients, it should be accompanied by the least possible adverse effects. In this study, we present a device designed to meet these objectives for assessing therapeutic response. This theranostic device is based on the use of magnetic resonance imaging and spectroscopy for the diagnostic aspect and on the application of the convection-enhanced delivery technique for the therapeutic aspect. The miniaturized device is implantable and can be used in vivo in a target tissue. In this study, the device was applied on rodent glioma models with localized administration of choline kinase inhibitor and acquisition of magnetic resonance images and spectra at 7 Tesla. The variations of concentration of key metabolites measured by the device during the administration of the molecules demonstrate the relevance of the approach and the potential of the device.

show abstract

Proton MRS on sub‐microliter volume in rat brain using implantable NMR microcoils

2021

Self Cite

View full text Add to dashboard Cite

The use of miniaturized NMR receiver coils is an effective approach for improving detection sensitivity in studies using MRS and MRI. By optimizing the filling factor (the fraction of the coil occupied by the sample), and by increasing the RF magnetic field produced per unit current, the sensitivity gain offered by NMR microcoils is particularly interesting when small volumes or regions of interest are investigated. For in vivo studies, millimetric or sub-millimetric microcoils can be deployed in tissues to access regions of interest located at a certain depth. In this study, the implementation and application of a tissue-implantable NMR microcoil with a detection volume of 850 nL is described. The RF magnetic field generated by the microcoil was evaluated using a finite element method simulation and experimentally determined by high spatial resolution MRI acquisitions. The performance of the microcoil in terms of spectral resolution and limit of detection was measured at 7 T in vitro and in vivo in rodent brains. These performances were compared with those of a conventional external detection coil. Proton MR spectra were acquired in the cortex of rat brain. The concentrations of main metabolites were quantified and compared with reference values from the literature. In vitro and in vivo results obtained with the implantable microcoil showed a gain in sensitivity greater than 50 compared with detection using an external coil. In vivo proton spectra of diagnostic value were obtained from brain regions of a few hundred nanoliters. The similarities between spectra obtained with the implanted microcoil and those obtained with the external NMR coil highlight the minimally invasive nature of the coil implantation procedure. These implantable microcoils represent new tools for probing tissue metabolism in very small healthy or diseased regions using MRS.

show abstract

Implantable NMR Microcoils in Rats: A New Tool for Exploring Tumor Metabolism at Sub-Microliter Scale?

Cited by 4 publications

References 24 publications

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact: application to brain tumors

Proton MRS on sub‐microliter volume in rat brain using implantable NMR microcoils

Contact Info

Product

Resources

About